Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

    Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi
    14-03-2022
    https://doi.org/10.4081/dr.2022.9091
    2668
    PDF: 658
    HTML: 16
  • Vitiligo: What’s old, what’s new

    Mariabeatrice Bertolani, Eleonora Rodighiero, Maria Beatrice de Felici del Giudice, Torello Lotti, Claudio Feliciani, Francesca Satolli
    15-09-2021
    https://doi.org/10.4081/dr.2021.9142
    2914
    PDF: 1195
    HTML: 231
  • The efficacy of apremilast in pemphigus: a systematic review of case reports

    Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri
    07-05-2025
    https://doi.org/10.4081/dr.2025.10245
    1053
    PDF: 465
    SUPPLEMENTARY MATERIAL: 70
    HTML: 20
  • The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

    Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi
    01-07-2025
    https://doi.org/10.4081/dr.2025.10112
    1028
    PDF: 768
    HTML: 40
  • Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

    Louise Rottboell, Sarah de Foenss, Kenneth Thomsen, Helle Christiansen, Stine M. Andersen, Thomas N. Dam, Cecilia Rosada, Karin Stenderup
    17-12-2015
    https://doi.org/10.4081/dr.2015.6246
    3240
    PDF: 979
    HTML: 766
  • Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study

    Tannaz Dehpouri, Ghasem Rahmatpour Rokni, Nematollah Ahangar Narenjbon, Mohamad Goldust, Paul S. Yamauchi, Uwe Wollina, Torello Lotti, Leon Kircik, Vito Giuseppe Di Lernia, Sidharth Sonthalia, Aleksandra Vojvodic, Jacek Szepietowski, Philippe Bahadoran, Enzo Errichetti, Carmen Cantisani, Laura Atzori, Elham Rezaee, Zekayi Kutlubay, Burhan Engin, Steven Nisticò, Giovanni Damiani, Rosalynn R.Z. Conic, Andy Goren, Leo Čabrijan, Georgi Tchernev
    09-05-2019
    https://doi.org/10.4081/dr.2019.7965
    2637
    PDF: 986
    HTML: 931
  • Calcipotriol as a daylight photodynamic therapy enhancer: a case-control study

    Benedetta Sonego, Enrico Zelin, Serena Bonin, Tommaso Pozzebon, Giulia Bazzacco, Andrea Corio, Marina Agozzino, Dante Raffaele Caro Caposiena, Iris Zalaudek, Nicola di Meo
    01-10-2024
    https://doi.org/10.4081/dr.2024.10077
    1147
    PDF: 538
    HTML: 105
  • Psoriasiform rash possibly induced by oral propranolol in a 12-month-old girl with infantile hemangioma: a case report and literature review

    Sahar Alruhaimi, Fatimah Alowirdi, Waleed Al-Ajroush
    05-03-2025
    https://doi.org/10.4081/dr.2025.10239
    670
    PDF: 374
    HTML: 35
  • Efficacy of a topical polyphenol-based formulation in palmoplantar psoriasis: an observational study

    Simone Amato, Annunziata Dattola, Luigi Bennardo, Martina Tolone, Steven Paul Nisticò
    08-07-2025
    https://doi.org/10.4081/dr.2025.10333
    552
    PDF: 376
    HTML: 36
  • Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

    Federica Mola, Alberico Motolese
    e40
    03-10-2011
    https://doi.org/10.4081/dr.2011.e40
    1316
    PDF: 621
    HTML: 1091
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1431
    PDF: 432
    HTML: 54
  • Atopic dermatitis: a brief review of recent advances in its management

    Sultan Daghafak Alenazi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9678
    2518
    PDF: 1454
    HTML: 128
  • Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

    Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone
    29-07-2021
    https://doi.org/10.4081/dr.2021.8797
    3162
    PDF: 670
    HTML: 20
  • Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

    Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza
    23-11-2022
    https://doi.org/10.4081/dr.2022.9476
    1528
    PDF: 514
    HTML: 35
  • Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

    Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi
    01-10-2018
    https://doi.org/10.4081/dr.2018.7859
    2130
    PDF: 1099
    HTML: 88
  • Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients, and vaccine-associated dermatoses: a clinical atlas and a large original study of two general COVID-19 centers from Iran

    Afsaneh Sadeghzadeh-Bazargan, Azadeh Goodarzi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9473
    1036
    PDF: 501
    SUPPLEMENTARY FILE: 169
    HTML: 26
  • Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

    Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
    17-03-2022
    https://doi.org/10.4081/dr.2022.9282
    1230
    PDF: 865
    HTML: 49
  • Late reaction to ustekinumab infusion

    Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho
    e2
    09-09-2013
    https://doi.org/10.4081/dr.2013.e2
    4001
    PDF: 693
    HTML: 270
  • Exacerbation of generalized plaque psoriasis after tuberculin test

    Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Walter Volpi, Marzia Caproni
    28-07-2021
    https://doi.org/10.4081/dr.2021.9019
    3210
    PDF: 534
    HTML: 306
  • Refractory pityriasis rubra pilaris treated with abrocitinib

    Filip Rob
    09-01-2025
    https://doi.org/10.4081/dr.2025.10105
    514
    PDF: 327
    HTML: 25
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1450
    PDF: 687
    HTML: 148
  • Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

    Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole
    19-06-2023
    https://doi.org/10.4081/dr.2023.9755
    909
    PDF: 443
    HTML: 25
  • Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

    Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti
    01-07-2025
    https://doi.org/10.4081/dr.2025.10315
    633
    PDF: 326
    HTML: 25
  • The role of calcium serum level in clinical manifestation and progress of psoriasis vulgaris in a patient with Fahr’s syndrome

    Migena Vargu, Sabina Dedej, Petrit Vargu, Eriselda Kurushi, Anxhela Nisi, Samuele Vargu
    28-10-2025
    https://doi.org/10.4081/dr.2025.10614
    272
    PDF: 170
    HTML: 9
  • A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

    Line Raaby, Kristian Otkjær, Maria Luise Salvskov-Iversen, Claus Johansen, Lars Iversen
    e14
    14-10-2010
    https://doi.org/10.4081/dr.2010.e14
    4172
    PDF: 871
    HTML: 329
26 - 50 of 126 items << < 1 2 3 4 5 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.